You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Breast Tumours

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Advanced Solid Tumors, NSCLC, Triple-negative Breast Cancer Trial in Barcelona, Madrid (OMO-103)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • OMO-103
  • Barcelona, Spain
  • +2 more
Sep 27, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Using Comprehensive Genomic Data on Next Treatment Decision

Active, not recruiting
  • Metastatic Breast Cancer
  • blood sample collection and collection of tumor tissue block
  • Barcelona, Please Select, Spain
    Translational Genomics and Targeted Therapeutics in Solid Tumour
Oct 24, 2022

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

Completed
  • Advanced Solid Tumors Amenable to Anthracycline Therapy
  • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
  • Münster, Germany
  • +1 more
Apr 1, 2022

Solid Tumor, Gastrointestinal Cancer, Breast Cancer Trial in Singapore (QPOP, CURATE.AI, Azacitidine + docetaxel)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • QPOP
  • +4 more
  • Singapore, Singapore
    National University Hospital
May 18, 2022

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

Recruiting
  • Advanced Solid Tumor
  • +13 more
  • Duarte, California
  • +3 more
Oct 25, 2022

Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer Trial in United Kingdom (Crizotinib Oral Capsule

Recruiting
  • Lobular Breast Carcinoma
  • +3 more
  • Crizotinib Oral Capsule [Xalkori]
  • Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic]
  • Glasgow, United Kingdom
  • +7 more
Nov 1, 2021

Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)

Recruiting
  • Clear Cell Renal Cell Cancer
  • +8 more
  • La Jolla, California
  • +22 more
Aug 12, 2022

Advanced Solid Tumours, Breast Cancer, Head Neck Cancer Trial in France (Durvalumab + Tremelimumab + metronomic Vinorelbine)

Active, not recruiting
  • Advanced Solid Tumours
  • +4 more
  • Durvalumab + Tremelimumab + metronomic Vinorelbine
  • Angers, France
  • +8 more
Jun 1, 2022

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in United Kingdom (AVA6000)

Recruiting
  • Pancreatic Cancer
  • +7 more
  • Glasgow, United Kingdom
  • +5 more
Nov 24, 2022

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Bladder Cancer, Triple Negative Breast Cancer, Castration-resistant Prostate Cancer Trial in London, Oxford (HMBD-001)

Recruiting
  • Bladder Cancer
  • +13 more
  • London, United Kingdom
  • +1 more
Dec 13, 2021

Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer Trial in Sutton (ASTX660, Pembrolizumab)

Recruiting
  • Advanced Cancer
  • +2 more
  • Sutton, United Kingdom
    Royal Marden NHS Foundation Trust
May 25, 2022

Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

Active, not recruiting
  • Melanoma
  • +9 more
  • MRx0518 Capsules
  • MRx0518/placebo Capsules
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Aug 10, 2022

NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Triple Negative Breast Cancer
  • Datopotamab Deruxtecan (Dato-DXd)
  • Beijing, China
  • +27 more
Aug 11, 2022

Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom

Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +3 more
Dec 19, 2022

Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

Recruiting
  • Breast Cancer
  • +7 more
  • Santa Monica, California
  • +19 more
Jan 6, 2022

Advanced Solid Tumours, Breast Cancer, Ovarian Cancer Trial in Beijing, Shanghai (IMP4297)

Completed
  • Advanced Solid Tumours
  • +3 more
  • Beijing, Beijing, China
  • +1 more
Mar 27, 2021

Advanced Solid Tumours, Breast Cancer, Ovarian Cancer Trial in Blacktown, Kogarah, Melbourne (IMP4297)

Completed
  • Advanced Solid Tumours
  • +4 more
  • Blacktown, New South Wales, Australia
  • +2 more
Mar 27, 2021

Breast Cancer Trial in Spain (Olaparib)

Terminated
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Jan 18, 2023

Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Imatinib 400 MG Oral Tablet
  • Gothenburg, Sweden
    Barbro Linderholm
Feb 1, 2023

Bladder Cancer Trial (Field-Cycling Imaging (FCI))

Not yet recruiting
  • Bladder Cancer
  • Field-Cycling Imaging (FCI)
  • (no location specified)
Apr 26, 2023

Breast Cancer Trial in London ([18F]GE-226)

Recruiting
  • Breast Cancer
  • [18F]GE-226
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Jan 3, 2023